These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5740704)

  • 21. Drugs for the treatment of neoplastic disease.
    Whitelaw DM
    Can Med Assoc J; 1965 Dec; 93(23):1217-8. PubMed ID: 5842596
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New derivatives of the Vinca rosea alkaloids.
    Armstrong JG
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):193-6. PubMed ID: 5659729
    [No Abstract]   [Full Text] [Related]  

  • 25. The chemotherapy of cancer in children.
    Keidan SE
    Proc R Soc Med; 1966 Mar; 59(3):211-2. PubMed ID: 5909761
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
    Ruggeri EM; Carlini P; Pollera CF; De Marco S; Ruscito P; Pinnarò P; Nardi M; Giannarelli D; Cognetti F
    Head Neck; 2005 Jun; 27(6):452-8. PubMed ID: 15880411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma.
    Jewkes J; Harper PG; Tobias JS; Geddes DM; Souhami RL; Spiro SG
    Cancer Treat Rep; 1983 Dec; 67(12):1119-21. PubMed ID: 6360349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytostatic therapy of lung and pleural neoplasms].
    Martz G; Danczkay I
    Bibl Tuberc; 1965; 20():176-85. PubMed ID: 5877566
    [No Abstract]   [Full Text] [Related]  

  • 31. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
    JOHNSON IS; ARMSTRONG JG; GORMAN M; BURNETT JP
    Cancer Res; 1963 Sep; 23():1390-427. PubMed ID: 14070392
    [No Abstract]   [Full Text] [Related]  

  • 33. Endodermal sinus tumor of the ovary: the M. D. Anderson experience.
    Gershenson DM; Del Junco G; Herson J; Rutledge FN
    Obstet Gynecol; 1983 Feb; 61(2):194-202. PubMed ID: 6185892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral Kaposi's sarcoma: role of radiotherapy].
    Conill C; Verger E; Ferrer F; Ferré J
    Med Clin (Barc); 1995 Mar; 104(11):436-7. PubMed ID: 7715266
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy of small cell carcinomas of the lung].
    Flicker M; Neumann M
    Wien Med Wochenschr; 1983 Aug; 133(15-16):397-402. PubMed ID: 6314680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
    Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S; Sulkes A; Gez E; Brufman G; Biran S
    Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with vincristine and 5-fluorouracil in advanced stages of carcinoma of the breast].
    Cardinali G; Nervi C
    Cancro; 1968; 21():Suppl 6:177+. PubMed ID: 5740706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.